Reckitt Benckiser appoints Suzanne LoGalbo to position of Regulatory Affairs Director, Reckitt Benckiser North America

Reckitt Benckiser (RB), a Parsippany-based global consumer goods leader in health, hygiene and home, recently announced the appointment of Suzanne LoGalbo to the position of Regulatory Affairs Director, Reckitt Benckiser North America.  LoGalbo joins RB from Pfizer Consumer Health.

While at Pfizer, LoGalbo most recently held the position of Global Regulatory Portfolio Lead Worldwide Regulatory Strategy. Prior to Pfizer, Suzanne was the head of Global Regulatory Affairs North America for Novartis Consumer Health.  She has also held regulatory leadership roles at Polaris, Solvay, Arganon and Sandoz. 

Suzanne brings with her significant global and North American leadership experience in the regulatory environment including Rx to OTC switches, compliance, government relations and global NPD rollouts within the consumer health space.  At RB, the US and Canadian regulator teams will now report to LoGalbo.

LoGalbo holds a Juris Doctor from Rutgers University School of Law and holds a BS in pharmaceutical studies.

Suggested Articles

In previously untreated nonsquamous NSCLC, a Tyvyt-chemo combo beat chemo alone at stalling the time to tumor progression or death.

It’s been a big year for Bristol's Opdivo-Yervoy combo in lung cancer, but with new mesothelioma data in hand, the duo isn’t done making headlines.

A third spinal muscular atrophy treatment option is set to debut with the FDA’s approval for Roche’s Evrysdi, formerly known as risdiplam.